Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report)’s stock price was up 7.9% during mid-day trading on Wednesday. The stock traded as high as $8.43 and last traded at $8.43. 100 shares changed hands during trading, a decline of 96% from the average daily volume of 2,379 shares. The stock had previously closed at $7.8150.
Nxera Pharma Stock Up 7.9%
The firm’s 50-day moving average is $7.31 and its 200 day moving average is $6.62.
Nxera Pharma Company Profile
Nxera Pharma Co, Ltd., formerly known as Sosei Group Corporation and Sosei Heptares, is a biopharmaceutical company focused on discovering and developing medicines that target G protein-coupled receptors (GPCRs). These receptors are involved in a wide range of biological processes and represent an important class of targets for treatments in areas including neuroscience, immunology, inflammation, metabolic disease and other therapeutic fields.
The company combines structure-based drug design, computational chemistry and its proprietary StaR technology to identify and optimize drug candidates.
See Also
- Five stocks we like better than Nxera Pharma
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
